ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Semper Paratus Acquisition Coporation

Semper Paratus Acquisition Coporation (LGST)

4.51
0.00
(0.00%)
Al cierre: 26 Diciembre 3:00PM
4.51
0.00
( 0.00% )
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
4.51
Postura de Compra
2.15
Postura de Venta
6.25
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
4.51
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
13,433,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-210.00
Beneficio por acción (BPA)
-0.01
turnover
-
Beneficio neto
-67k

Acerca de Semper Paratus Acquisition Coporation

Semper Paratus Acquisition Corp is a special purpose acquisition company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Semper Paratus Acquisition Corp is a special purpose acquisition company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Sector
Biological Pds,ex Diagnstics
Industria
Blank Checks
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2024

LGST Últimas noticias

Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN

Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for...

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio

New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company...

Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq

New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today...

Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination

The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion.Tevogen Bio is an advanced-stage...

Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement

New York, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST, the “Company”) announced today that it received a letter from the Listing Qualifications...

Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today announced...

Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation

Tevogen Bio Inc. (“Tevogen Bio”) is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

LGST - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Semper Paratus Acquisiti...?
El precio actual de las acciones de Semper Paratus Acquisiti... es US$ 4.51
¿Cuántas acciones de Semper Paratus Acquisiti... están en circulación?
Semper Paratus Acquisiti... tiene 13,433,000 acciones en circulación
¿Cuál es la capitalización de mercado de Semper Paratus Acquisiti...?
La capitalización de mercado de Semper Paratus Acquisiti... es USD 60.58M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Semper Paratus Acquisiti...?
Semper Paratus Acquisiti... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Semper Paratus Acquisiti...?
El ratio precio/beneficio de Semper Paratus Acquisiti... es -210
¿Cuál es la moneda de reporte de Semper Paratus Acquisiti...?
Semper Paratus Acquisiti... presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Semper Paratus Acquisiti...?
El último beneficio anual de Semper Paratus Acquisiti... es USD -67k
¿Cuál es la dirección registrada de Semper Paratus Acquisiti...?
La dirección registrada de Semper Paratus Acquisiti... es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Semper Paratus Acquisiti...?
La dirección del sitio web de Semper Paratus Acquisiti... es www.tevogen.com/
¿En qué sector industrial opera Semper Paratus Acquisiti...?
Semper Paratus Acquisiti... opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
INTZIntrusion Inc
US$ 0.89
(97.78%)
2.19M
EVAXEvaxion Biotech AS
US$ 1.61
(90.31%)
6.84M
LIDRAEye Inc
US$ 1.90
(48.44%)
1.87M
JSPRWJasper Therapeutics Inc
US$ 0.25
(47.06%)
343
CRKNCrown Electrokinetics Corporation
US$ 0.1834
(39.26%)
28.82M
VIRXViracta Therapeutics Inc
US$ 0.1949
(-17.76%)
344.64k
XELBXcel Brands Inc
US$ 0.4401
(-15.19%)
35.45k
LGCBLinkage Global Inc
US$ 0.39
(-14.66%)
33.92k
MITAColiseum Acquisition Corporation
US$ 10.00
(-13.12%)
11.02k
LVROLavoro Ltd
US$ 4.50
(-12.62%)
16.05k
CRKNCrown Electrokinetics Corporation
US$ 0.1834
(39.26%)
28.82M
OMEXOdyssey Marine Exploration Inc
US$ 0.6015
(25.18%)
9.45M
EVAXEvaxion Biotech AS
US$ 1.61
(90.31%)
6.84M
KITTNauticus Robotics Inc
US$ 2.3791
(33.66%)
5.1M
XTIAXTI Aerospace Inc
US$ 0.0401
(0.25%)
4.77M
work-n-hard work-n-hard 2 minutos hace
A little after hours action. How about a PR telling us that the $13M deal closed? 😁
JFBR
skitahoe skitahoe 2 minutos hace
I've seen many companies where additional trials were required, it hurts, but if what's requested is deemed reasonable by shareholders the companies have survived, and ultimately thrived. I don't believe it will be needed here, but if I'm wrong, it's already been driven so low that a well designed
NWBO
Real McCoy Real McCoy 3 minutos hace
Bioamber has shareholders?

Wasn’t trading stopped years ago??
ProfitChaser ProfitChaser 3 minutos hace
I dont own this one or know anything about it. Just saw the article and thought I would mention it incase anyone else wants to gamble. I might would grab a little if it was on a different exchange.

https://www.coinspeaker.com/600-in-this-token-could-reach-30000-in-the-next-10-weeks/?
Green doggie Green doggie 4 minutos hace
What makes you think he’s getting ousted? China did away with two term limits and Xi could be in for life.
DRGV
dennisdave dennisdave 4 minutos hace
Clearly the P3 was a mess and they need to run a better trial, but the P3 failure was possibly due to a bad design by NWBO.
thats why the MHRA bought into NWBO pediatric SAP, being the exact same as the DCVAXL trial, because the trial design was a mess?
NWBO
bas2020 bas2020 5 minutos hace
Typical... FUDster truncated the sentence to fit his FUD narrative.
NWBO
Dodger1 Dodger1 5 minutos hace
tally ho

Go $AABB
AABB
work-n-hard work-n-hard 5 minutos hace
Jeepers, maybe that's it? .....this time
TSOI
PinkPennies PinkPennies 5 minutos hace
CRKN ..172 news https://finance.yahoo.com/news/crown-ceo-issues-letter-shareholders-213000435.html
CRKN
Sideem Sideem 5 minutos hace
I'll take the $3.92. It's actually only down a penny if the shortened day closing price of $3.93 at 1pm is believed. Guess it can't go up everyday even if I want it to...LOL.
BB
work-n-hard work-n-hard 6 minutos hace
https://investorshub.advfn.com/uimage/uploads/2024/12/26/ppwtnScreenshot_2024-12-26_at_17-56-30_Therapeutic_Solutions_(PK)_(TSOI)_-_Trades_-_ADVFN.png
TSOI
Telling you there’s a chance Telling you there’s a chance 6 minutos hace
I’m actually trying to offer you guys a way to get your money back Fast!

Would you like to know how KCCO is going to make his money back?

He invested more money into Poet on Dec 16. He’s doing great so far, in a few years when Poet is way up there in the forties or fift
LWLG
VOIP20 VOIP20 6 minutos hace
Has anyone checked out the new Viper website? It is an improvement over the old one, but not by much. However, I did find this fascinating tidbit of information under the Updates section. As follows: "The company implemented 108 slim line poles equipped with state of the art LED lighting" in Columbo
VPER
Jake731 Jake731 6 minutos hace
I guess we'll sit back and let it play out. Do we have a choice ? 
TPTW
EmpressMonk25 EmpressMonk25 7 minutos hace
Patience follows those invested, impatience follows those who want failure...or daytraders which you are not!
HMBL
misterfishman misterfishman 7 minutos hace
True and nice close today.
RDAR
Bjones2 Bjones2 7 minutos hace
No Dilution, No New shares issued, LOL

Shares for the debt came from Artizen Founders holdings. Read the reports
PVSP
Bjones2 Bjones2 7 minutos hace
No Dilution, No New shares issued, LOL

Shares for the debt came from Artizen Founders holdings. Read the reports
PVSP
TMaga TMaga 8 minutos hace
You are correct. Almost three years now. Cozen screwed up the first patent and the first court that looked at the lawsuit threw it out. HCMC appealed. The appeals court said the patent that Cozen supposedly fixed looked OK enough to send it back to the new court. The appeals court said they would as
HCMC
karlacorn3 karlacorn3 8 minutos hace
Hello RD. Searching for good news :-). Do you if the $500k wire was received? And do you know if the Hong Kong trip took place to release the $100M
K
https://investorshub.advfn.com/uimage/uploads/2024/12/26/pmffpScreenshot_2024-12-26_141957.png
ITUP
manibiotech manibiotech 8 minutos hace
NWBO has no ownership or management stake in advent 
NWBO
OMOLIVES OMOLIVES 9 minutos hace
Yep...and they keep focusing on the incorrect things regarding WSCG Inc:

https://www.otcmarkets.com/filing/html?id=17033449&guid=lKY-kHdxdv3Th3h

Given the debt loads and share structures of everything mentioned here, absolutely no one has paid attention to share structu
HMBL
PROPHET-of-PROFITS PROPHET-of-PROFITS 9 minutos hace
Really strong trading going into end of year. If it is like this now January could be amazing...
RDAR

Su Consulta Reciente

Delayed Upgrade Clock